BlackRock Fund Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$4.01M	Buy	183,797 +30,455	+20%	+$665K	﹤0.01%	3003
2016 Q3	$4.04M	Buy	153,342 +6,245	+4%	+$165K	﹤0.01%	2938
2016 Q2	$2.91M	Buy	+147,097	New	+$2.91M	﹤0.01%	3089